542934 — Chandra Bhagat Pharma Share Price
0.000.00%
Last trade - 00:00- IN₹452.70m
- IN₹650.49m
- IN₹2.21bn
- 52
- 41
- 13
- 24
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.52 | ||
| Price to Tang. Book | 1.52 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.27 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -12.73% | ||
| Return on Equity | 5.47% | ||
| Operating Margin | -2.32% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 939.81 | 706.95 | 940.76 | 1,196.72 | 2,213.72 | n/a | n/a | 15.81% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -39.72 | -54.56 | +355.36 | +13.18 | +63.38 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Chandra Bhagat Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the business of marketing pharmaceutical critical care and health care products. The Company is focused on marketing pharmaceutical formulations and products in the domestic and international market through its own distribution network and sales under its own brand. It focuses on Injection - IV (Intravenous) and IM (Intramuscular), tablets and capsules supplied to hospitals and health care centers for critical diseases. The Company also deals in importing and supplying active pharmaceutical ingredients (API) and its intermediates. The Company also has its presence in the therapeutic categories for formulations such as anti-cancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, antifungal, antiviral, pediatrics, cardiology, nephrology, and neurology. It is also engaged in promoting and marketing of API in India.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- March 10th, 2003
- Public Since
- February 14th, 2020
- No. of Employees
- 37
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 7,545,056
- Address
- 323-F Bhagat Bhuvan, MUMBAI, 400019
- Web
- https://cbcpharma.com/
- Phone
- +91 2224146154
- Auditors
- A Y & Company
Upcoming Events for 542934
Similar to 542934
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the Chandra Bhagat Pharma share price?
As of Today at 19:52 UTC, shares in Chandra Bhagat Pharma are trading at IN₹60.00. This share price information is delayed by 15 minutes.
How has the Chandra Bhagat Pharma share price performed this year?
Shares in Chandra Bhagat Pharma last closed at IN₹60.00 and the price had moved by -41.19% over the past 365 days. In terms of relative price strength the Chandra Bhagat Pharma share price has underperformed the S&P BSE 100 Index by -44.6% over the past year.
What are the analyst and broker recommendations for Chandra Bhagat Pharma?
There is no consensus recommendation for this security.
Find out moreWhat is the Chandra Bhagat Pharma dividend yield?
Chandra Bhagat Pharma does not currently pay a dividend.
Does Chandra Bhagat Pharma pay a dividend?
Chandra Bhagat Pharma does not currently pay a dividend.
When does Chandra Bhagat Pharma next pay dividends?
Chandra Bhagat Pharma does not currently pay a dividend.
How do I buy Chandra Bhagat Pharma shares?
To buy shares in Chandra Bhagat Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Chandra Bhagat Pharma?
As of the previous close price of IN₹60.00, shares in Chandra Bhagat Pharma had a market capitalisation of IN₹452.70m.
Where are Chandra Bhagat Pharma shares listed?
Here are the trading details for Chandra Bhagat Pharma:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 542934
What kind of share is Chandra Bhagat Pharma?
Based on an overall assessment of its quality, value and momentum Chandra Bhagat Pharma is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Chandra Bhagat Pharma share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Chandra Bhagat Pharma share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chandra Bhagat Pharma. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -13.69%.
As of the last closing price of IN₹60.00, shares in Chandra Bhagat Pharma were trading -32.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Chandra Bhagat Pharma PE Ratio?
The Chandra Bhagat Pharma PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹60.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Chandra Bhagat Pharma?
Chandra Bhagat Pharma's management team is headed by:
- Hemant Bhagat - CHM
- Prachi Bhagat - CFO
- Pranav Bhagat - EDR
- Ravindra Awati - NID
- Abha Doshi - NID